Article info

Download PDFPDF

Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3

Authors

  • Adam Shardlow Renal Medicine, Royal Derby Hospital, Derby, UK Division of Medical Sciences and Graduate Entry Medicine, Centre for Kidney Research and Innovation, School of Medicine, The University of Nottingham, Royal Derby Hospital, Derby, UK PubMed articlesGoogle scholar articles
  • Natasha J McIntyre Renal Medicine, Royal Derby Hospital, Derby, UK PubMed articlesGoogle scholar articles
  • Richard J Fluck Renal Medicine, Royal Derby Hospital, Derby, UK PubMed articlesGoogle scholar articles
  • Christopher W McIntyre Division of Nephrology, Schulich School of Medicine and Dentistry University of Western Ontario, London, Ontario, Canada PubMed articlesGoogle scholar articles
  • Maarten W Taal Renal Medicine, Royal Derby Hospital, Derby, UK Division of Medical Sciences and Graduate Entry Medicine, Centre for Kidney Research and Innovation, School of Medicine, The University of Nottingham, Royal Derby Hospital, Derby, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Adam Shardlow; adam.shardlow{at}nhs.net
View Full Text

Citation

Shardlow A, McIntyre NJ, Fluck RJ, et al
Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3

Publication history

  • Received February 23, 2017
  • Revised May 30, 2017
  • Accepted June 22, 2017
  • First published August 23, 2017.
Online issue publication 
August 23, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.